Sec Form 13D Filing - Horton Capital Partners LLC filing for KORU Medical Systems Inc. (KRMD) - 2020-08-20

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 7)

REPRO MED SYSTEMS, INC.

(Name of Issuer)

Common Stock, Par Value $0.01 Per Share

(Title of Class of Securities)

759910102

(CUSIP Number)

JOSEPH M. MANKO, JR.

HORTON CAPITAL PARTNERS, LLC

1717 Arch Street, Suite 3920

Philadelphia, PA 19103

(215) 399 5402

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

August 20, 2020

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.  ☐

NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

CUSIP No. 759910102

CUSIP No. 759910102

CUSIP No. 759910102

CUSIP No. 759910102

CUSIP No. 759910102

Item 1. Security and Issuer.

This statement relates to shares of common stock, par value $0.01 per share (“Common Stock”), of Repro Med Systems, Inc., a New York corporation (the “Issuer”). The address of the principal executive offices of the Issuer is 24 Carpenter Road, Chester, NY 10918.

Horton Capital Partners Fund, LP, a Delaware limited partnership (“HCPF”), Horton Freedom, LP, a Delaware limited partnership (“Horton Freedom”), Horton Capital Partners LLC, a Delaware limited liability company (“HCP”), Horton Capital Management, LLC, a Delaware limited liability company (“HCM”), and Joseph M. Manko, Jr. (“Mr. Manko”) filed Schedule 13D with the Securities and Exchange Commission (the “SEC”) on May 23, 2017, as amended by Amendments Nos. 1 – 6 filed on December 4, 2017, December 21, 2017, March 16, 2018, September 20, 2018, December 21, 2018, and January 29, 2020 (“Schedule 13D”), to report their beneficial ownership of the shares of Common Stock of the Issuer. This Amendment No. 7 (“Amendment No. 7”) is filed with the SEC to amend and supplement Schedule 13D.

Item 2. Identity and Background.

(a) This statement is filed by HCPF, Horton Freedom, HCP, HCM, and Mr. Manko (Mr. Manko together with HCPF, Horton Freedom, HCP and HCM, the “Reporting Persons” and each a “Reporting Person”), with respect to shares of Common Stock of the Issuer.

(b) The address of the principal office of each Reporting Person is 1717 Arch Street, Suite 3920, Philadelphia, PA 19103. The managing member of HCP and HCM is Mr. Joseph M. Manko, Jr.

(c) The principal business of HCPF, Horton Freedom and HCP is purchasing, holding, and selling securities for investment purposes. The principal business of HCM is serving as the investment manager of HCPF, Horton Freedom, and separately managed accounts (“SMAs”). HCP is the general partner of HCPF and Horton Freedom. The principal occupation of Mr. Manko is serving as the managing member of HCM and HCP.

(d) No Reporting Person has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

(e) No Reporting Person has, during the last five years, been party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.

(f) Mr. Manko is a citizen of the United States of America.

Item 3. Source and Amounts of Funds or other Consideration.

The responses to Item 4 of this Amendment No. 7 are incorporated herein by reference. Unless otherwise disclosed below, the Reporting Persons used working capital to acquire shares of Common Stock.

Item 4. Purpose of Transaction.

The Reporting Persons acquired the shares of Common Stock for investment purposes. The purpose of this Amendment is to disclose the transfer of 401,929 shares of Common Stock to an SMA client (the “Client”) pursuant to the termination of such client’s investment advisory agreement with HCM.

On August 7, 2019, HCPF exercised the Warrant to purchase 1,000,000 shares of Common Stock, dated August 8, 2014, in full. The Warrant was issued to HCPF pursuant to the Securities Purchase Agreement (the “SPA”) with the Issuer, dated August 8, 2014. The Warrant included a conversion cap that precluded HCPF from exercising the Warrant to the extent that HCPF would, after such exercise, beneficially own (as determined in accordance with Section 13(d) of the Act) in excess of 9.99% of the shares of Common Stock then outstanding, unless HCPF elects to waive this provision with the agreement of the Issuer. On August 31, 2018 HCPF waived this provision and the Issuer acknowledged the waiver on September 12, 2018.

On September 30, 2019, 1,899 shares of Common Stock were issued to HCPF, on December 31, 2019, 1,149 shares of Common Stock were issued to HCPF, on March 31, 2020 1,000 shares of Common Stock were issued to HCPF, and on June 30, 2020 835 shares of Common Stock were issued to HCPF in consideration for Mr. Manko’s service as a director (collectively, “Director Shares”).

On January 6, 2020, HCPF transferred 401,929 shares of Common Stock to HCM for a managed client account (“Horton Managed Account”) under the investment advisory agreement with the client.

On January 24, 2020, Horton Freedom transferred 125,931 shares of Common Stock to one of its limited partners, for no consideration, representing 100% of such limited partner’s interest in Horton Freedom.

On August 18, 2020, the Horton Managed Account terminated that certain investment advisory agreement with HCM. As a result, HCM no longer retains voting or dispositive power with respect to the 401,929 shares of Common Stock held in the Horton Managed Account (the “Managed Account Termination”), representing 100% of the client’s interest in the Issuer. Following the Managed Account Termination, under investment advisory agreements with other SMAs, HCM has discretionary investment and voting authority with respect to 1,123,110 shares of Common Stock held in such SMAs.

Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of shares of Common Stock at prices that would make the purchase or sale of such shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of shares of Common Stock on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable.

No Reporting Person has any present plan or proposal which would relate to or result in any of the matters set forth in subparagraphs (a) - (j) of Item 4 of the form of Schedule 13D, except as set forth herein, or such as would occur upon or in connection with completion of, or following, any of the actions discussed herein. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer’s financial position and investment strategy, the price levels of the shares of Common Stock of the Issuer, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, engaging in additional communications with management and the Board of the Issuer, engaging in discussions with stockholders of the Issuer and others about the Issuer and the Reporting Persons’ investment, making proposals to the Issuer concerning changes to the capitalization, ownership structure, board structure (including board composition) or operations of the Issuer, purchasing additional shares of Common Stock, selling some or all of their shares of Common Stock, or changing their intention with respect to any and all matters referred to in Item 4.

Notwithstanding any of the foregoing, the Reporting Persons may at any time modify, change, abandon, or replace, some or all of the foregoing purposes and plans and discussions relating thereto or discontinue or re-continue such modifications, changes, abandonments, or replacements at any time.

Item 5. Interest in Securities of the Issuer.

(a)-(b) The percentages used herein are calculated based upon 43,909,570 shares of Common Stock issued and outstanding as of August 5, 2020, pursuant to the Quarterly Report on Form 10-Q filed by the Issuer with the SEC on August 5, 2020.

As of the close of business on August 20, 2020:

1. HCPF

(a) Amount beneficially owned: 7,369,216*

(b) Percent of class: 16.78%*

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 7,369,216*

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 7,369,216*

(c) HCPF has not entered into any transactions in the securities of the Issuer during the past 60 days.

2. Horton Freedom

(a) Amount beneficially owned: 3,283,593*

(b) Percent of class: 7.48%*

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 3,283,593*

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 3,283,593*

(c) Horton Freedom has not entered into any transactions in the securities of the Issuer during the past 60 days.

3. HCP

(a) Amount beneficially owned: 10,652,809*

(b) Percent of class: 24.26%*

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 10,652,809*

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 10,652,809*

(c) HCP has not entered into any transactions in the securities of the Issuer during the past 60 days.

4. HCM

(a) Amount beneficially owned: 11,775,919*

(b) Percent of class: 26.82%*

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 11,775,919*

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 11,775,919*

(c) HCM has not entered into any transactions in the securities of the Issuer during the past 60 days. See Item 4 above regarding the Managed Account Termination.

5. Mr. Manko

(a) Amount beneficially owned: 11,775,919*

(b) Percent of class: 26.82%*

(i) Sole power to vote or direct the vote: 0

(ii) Shared power to vote or direct the vote: 11,775,919*

(iii) Sole power to dispose or direct the disposition: 0

(iv) Shared power to dispose or direct the disposition: 11,775,919*

(c) Mr. Manko has not entered into any transactions in the securities of the Issuer during the past 60 days. See Item 4 above regarding the Managed Account Termination.

* HCPF owns directly 7,369,216 shares of Common Stock. Horton Freedom owns directly 3,283,593 shares of Common Stock. Following the Transfer, pursuant to investment advisory agreements, HCM maintains discretionary investment and voting authority with respect to 7,369,216, 3,283,593, and 1,123,110 shares of Common Stock held by HCPF, Horton Freedom, and the SMAs, respectively. HCP may be deemed to be the beneficial owner of such shares of Common Stock because, in the event HCM’s investment advisory agreements with respect to such shares of Common Stock are terminated, HCP has the right to assume HCM’s discretionary investment and voting authority with respect to such shares of Common Stock. HCP is the general partner of HCPF and Horton Freedom. Mr. Manko is the managing member of both HCM and HCP and may be deemed to be the beneficial owner of the shares of Common Stock held by HCPF, Horton Freedom, and the SMAs. Each of HCM, HCP, and Mr. Manko disclaims beneficial ownership of the shares of Common Stock held by HCPF, Horton Freedom, and the SMAs.

(d) No person other than the Reporting Persons is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, the Shares.

(e) Not applicable.

HCPF entered into the SPA and was issued the Warrant described in Item 4 above. Mr. Manko is a member of the Issuer’s Board of Directors.

The Reporting Persons have entered into a Joint Filing Agreement, attached hereto as Exhibit 1, pursuant to which they have agreed to file this Amendment No. 7 jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

The responses to Items 3, 4, and 5 of this Amendment No. 7 are incorporated herein by reference.

Other than as described herein, there are no contracts, arrangements, understandings, or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is true, complete, and correct.